Reconstituted Semaglutide GLP-1 should be stored under refrigeration at 4 C (39 F) and used within the active research timeframe described in the Amount & Handling tab
This research showed a positive correlation between the dose and duration of oral Setria and increased glutathione levels
FDA review takes 1012 months under standard review, or approximately 6 months if priority review is granted, putting approval between Q3 2027 and Q1Q2 2028, with commercial launch following 13 months later
In clinical trials, gastrointestinal adverse events were reported by a significant proportion of patients, though most were mild to moderate in severity and transient in nature
Like any medication, injectable weight loss can cause side effects
Bourron O, Ciangura C, Bouillot JL, Massias L, Poitou C, Oppert JM